April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Tudca Preserves Cones in Fast Degenerating Rd1 Mice
Author Affiliations & Notes
  • S. K. Arora
    Rehab R & D Center, Atlanta VA Medical Center, Decatur, Georgia
    Ophthalmology, Emory University, Atlanta, Georgia
  • A. Faulkner
    Rehab R & D Center, Atlanta VA Medical Center, Decatur, Georgia
  • M. Kim
    Rehab R & D Center, Atlanta VA Medical Center, Decatur, Georgia
  • V. Ciavatta
    Rehab R & D Center, Atlanta VA Medical Center, Decatur, Georgia
  • M. Pardue
    Rehab R & D Center, Atlanta VA Medical Center, Decatur, Georgia
    Ophthalmology, Emory University, Atlanta, Georgia
  • Footnotes
    Commercial Relationships  S.K. Arora, None; A. Faulkner, None; M. Kim, None; V. Ciavatta, None; M. Pardue, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 978. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. K. Arora, A. Faulkner, M. Kim, V. Ciavatta, M. Pardue; Tudca Preserves Cones in Fast Degenerating Rd1 Mice. Invest. Ophthalmol. Vis. Sci. 2009;50(13):978.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recently, the bile acid, tauroursodeoxycholic acid (TUDCA), has been shown to have anti-apoptotic properties in neurodegenerative diseases, including photoreceptor degeneration seen in retinitis pigmentosa (RP). Previous studies showed preservation of rods and cones in the rd10 mouse. This study examined whether TUDCA will preserve cones in the fast degenerating rd1 mouse model.

Methods: : Rd1 mice received daily intraperitoneal injections of TUDCA (500 mg/kg; n = 19) or vehicle (0.15 M NaHCO3, 1ml/kg; n = 18) beginning at postnatal day 6 (P6) and ending at P21. At P21, retinal function was measured with light adapted electroretinograms (ERG). Eyes were processed for histology to assess cone survival with photoreceptor counts and immunohistochemistry.

Results: : TUDCA-treated rd1 mice had 50% greater ERG b-wave amplitudes compared to vehicle-treated mice (ANOVA p<0.001). The number of photoreceptors in TUDCA-treated rd1 mice was approximately twice that in vehicle-treated mice.

Keywords: neuroprotection • retinal degenerations: hereditary • taurine 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×